Castle Biosciences opens new laboratory and office facility in Scottsdale Arizona

Castle Biosciences opens new laboratory and office facility in Scottsdale Arizona
Castle Biosciences opens Arizona site

Castle Biosciences has opened a new laboratory and office facility in Scottsdale, Arizona.

The company plans to mark this milestone with a grand opening celebration at 8667 E. Hartford Drive on Tuesday, October 6, 2026, at 3:30 pm MST. The new site is set to bolster Castle Biosciences' presence and operational capabilities in the region.

Earlier this year, Castle Biosciences started a dual listing on Nasdaq Texas while maintaining its primary listing under the ticker CSTL. The company recently published a multi-center study validating the accuracy of its DecisionDx-SCC test for high-risk squamous cell carcinoma patients. These developments reflect Castle Biosciences’ efforts to expand its reach and enhance its clinical offerings.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.